查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1528925

行動心臟遙測系統市場 - 按產品類型、適應症、最終用途 - 全球預測

Mobile Cardiac Telemetry Systems Market - By Product Type, Indication, End-use - Global Forecast
出版日期: | 出版商: Global Market Insights Inc. | 英文 105 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在不斷推出的產品和該領域的進步的推動下，全球行動心臟遙測系統市場在 2024 年至 2032 年間的複合年成長率將達到 12.1%。這些系統可以在傳統臨床環境之外即時監測心臟活動，從而對心臟疾病提供早期檢測和介入。領先的公司正在創新，推出更小、更便攜的設備，配備先進的感測器和連接功能，提高患者的舒適度和資料準確性。例如，2024 年 5 月，Vivalink 推出了專為行動心臟遙測 (MCT) 和動態心電圖監測量身定做的綜合技術解決方案。此整合解決方案將遠端患者監護 (RPM) 技術與檢測心律不整的先進演算法相結合。

全球心血管疾病的增加，加上人口老化，進一步推動了市場的發展。移動心臟遙測系統可以長時間持續監測，提高診斷準確性及患者治療效果。此外，將人工智慧和機器學習整合到這些系統中可以增強資料解釋和診斷能力。隨著醫療保健提供者優先考慮遠端患者監測和個人化護理，行動心臟遙測系統市場有望透過持續的技術創新實現顯著成長。

行動心臟遙測系統產業的整體規模根據產品類型、適應症、最終用途和地區進行分類。

由於貼片解決方案在連續心臟監測方面的便利性和有效性，行動心臟遙測系統市場對基於貼片的解決方案的需求不斷成長。這些穿戴式貼片提供心臟活動的即時資料，使患者和醫療保健提供者能夠深入了解心臟健康狀況，而不受傳統監測設備的限制。基於貼片的系統因其舒適性、易用性以及及時檢測心律不整和其他心臟異常的能力而越來越受歡迎。隨著醫療保健行業轉向遠端患者監測和個人化護理，在持續的技術進步和改善的患者治療結果的支持下，對基於貼片的行動心臟遙測系統的需求預計將會成長。

由於冠狀動脈疾病 (CAD) 盛行率不斷上升，移動心臟遙測系統市場對冠狀動脈監測解決方案的需求不斷增加。這些系統能夠持續監測患者的心臟活動，這對於早期發現和管理 CAD 相關問題至關重要。行動心臟遙測提供心臟功能的即時資料，幫助醫療保健提供者及時介入以預防併發症。由於 CAD 是全球死亡的主要原因，因此對能夠遠端檢測和監測冠狀動脈狀況的有效監測解決方案的需求正在推動市場成長並改善患者護理和治療結果。

由於醫療保健技術的進步和心血管疾病盛行率的增加，歐洲的行動心臟遙測系統市場正經歷著強勁的需求。這些系統可在臨床環境之外持續監測心臟活動，並支持早期診斷和個人化治療。歐洲醫療保健系統優先考慮遠距患者監測，以改善治療結果並減少住院率。隨著人口老化和慢性病發病率上升，對高效心臟監測解決方案的需求日益成長。行動心臟遙測技術的創新，包括增強的資料分析和連接性，滿足了這些需求，為歐洲市場在未來幾年的顯著成長奠定了基礎。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 心臟疾病的發生率增加
      • 政府優惠政策
      • 人口老化加劇
    • 產業陷阱與挑戰
      • 缺乏專業培訓和教育
      • 嚴格的監管政策和品質控制標準
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場估計與預測：按產品類型，2021 - 2032

  • 主要趨勢
  • 鉛基
  • 基於補丁

第 6 章：市場估計與預測：按指標分類，2021 - 2032 年

  • 主要趨勢
  • 心絞痛
  • 冠狀動脈疾病
  • 動脈粥狀硬化
  • 心臟衰竭
  • 中風
  • 其他適應症

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 專科診所
  • 診斷中心
  • 家庭護理設置
  • 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • ACS Diagnostics
  • Baxter International Inc.
  • BIOTRICITY INC.
  • Boston Scientific Cardiac Diagnostics Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medicomp Systems
  • ScottCare Cardiovascular Solutions
  • Telerhythmics LLC
  • Zoll Medical Corporation
簡介目錄
Product Code: 9376

Global Mobile Cardiac Telemetry Systems Market will witness a 12.1% CAGR between 2024 and 2032, fueled by continuous product launches and advancements in the field. These systems offer real-time monitoring of cardiac activities outside of traditional clinical settings, providing early detection and intervention for cardiac conditions. Leading companies are innovating with smaller, more portable devices equipped with advanced sensors and connectivity features, enhancing patient comfort and data accuracy. For instance, in May 2024, Vivalink introduced a comprehensive technology solution tailored for Mobile Cardiac Telemetry (MCT) and Holter monitoring. This integrated solution combines remote patient monitoring (RPM) technologies with advanced algorithms for detecting arrhythmias.

The rise in cardiovascular diseases globally, coupled with an aging population, drives the market further. Mobile cardiac telemetry systems enable continuous monitoring over extended periods, improving diagnostic accuracy and patient outcomes. Additionally, the integration of artificial intelligence and machine learning into these systems enhances data interpretation and diagnostic capabilities. As healthcare providers prioritize remote patient monitoring and personalized care, the Mobile Cardiac Telemetry Systems Market is poised for significant growth with ongoing technological innovations.

The overall Mobile Cardiac Telemetry Systems Industry size is classified based on the product type, indication, end-use, and region.

The Mobile Cardiac Telemetry Systems Market is experiencing rising demand for patch-based solutions due to their convenience and effectiveness in continuous heart monitoring. These wearable patches provide real-time data on cardiac activity, offering patients and healthcare providers insights into heart health without the constraints of traditional monitoring devices. Patch-based systems are gaining popularity for their comfort, ease of use, and ability to detect arrhythmias and other cardiac abnormalities promptly. As the healthcare industry shifts towards remote patient monitoring and personalized care, the demand for patch-based mobile cardiac telemetry systems is expected to grow, supported by ongoing technological advancements and improved patient outcomes.

The Mobile Cardiac Telemetry Systems Market is seeing increased demand for coronary artery monitoring solutions, driven by the rising prevalence of coronary artery disease (CAD). These systems enable continuous monitoring of patients' heart activity, crucial for the early detection and management of CAD-related issues. Mobile cardiac telemetry provides real-time data on heart function, helping healthcare providers intervene promptly to prevent complications. With CAD being a leading cause of mortality worldwide, the need for effective monitoring solutions that can detect and monitor coronary artery conditions remotely is driving market growth and enhancing patient care and outcomes.

The Mobile Cardiac Telemetry Systems Market in Europe is experiencing robust demand driven by advancements in healthcare technology and increasing cardiovascular disease prevalence. These systems offer continuous monitoring of cardiac activity outside clinical settings, supporting early diagnosis and personalized treatment. European healthcare systems prioritize remote patient monitoring to improve outcomes and reduce hospitalizations. As aging populations and chronic disease rates rise, there's a growing need for efficient cardiac monitoring solutions. Innovations in mobile cardiac telemetry, including enhanced data analytics and connectivity, cater to these needs, positioning the European market for significant growth in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of cardiac disorders
      • 3.2.1.2 Favorable government policies
      • 3.2.1.3 Growing aging population
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Lack of professional training & education
      • 3.2.2.2 Stringent regulatory policies and quality control standards
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Lead-based
  • 5.3 Patch-based

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Angina pectoris
  • 6.3 Coronary artery disease
  • 6.4 Atherosclerosis
  • 6.5 Heart failure
  • 6.6 Stroke
  • 6.7 Other indications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Specialty clinics
  • 7.4 Diagnostic centers
  • 7.5 Homecare settings
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 ACS Diagnostics
  • 9.2 Baxter International Inc.
  • 9.3 BIOTRICITY INC.
  • 9.4 Boston Scientific Cardiac Diagnostics Inc.
  • 9.5 iRhythm Technologies, Inc.
  • 9.6 Koninklijke Philips N.V.
  • 9.7 Medicomp Systems
  • 9.8 ScottCare Cardiovascular Solutions
  • 9.9 Telerhythmics LLC
  • 9.10 Zoll Medical Corporation